GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cd14 | decreases expression | ISO | CD14 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in decreased expression of CD14 mRNA | PMID:22521957 | Cd14 | increases expression | ISO | CD14 (Homo sapiens) | 6480464 | CTD | Arsenic Trioxide results in increased expression of CD14 mRNA; Arsenic Trioxide results in increased expression of CD14 protein | PMID:20226526 PMID:23911876 | Cd14 | increases expression | ISO | Cd14 (Mus musculus) | 6480464 | CTD | Arsenic Trioxide results in increased expression of CD14 mRNA | PMID:15073043 | Cd14 | multiple interactions | ISO | CD14 (Homo sapiens) | 6480464 | CTD | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]]; [Gefitinib promotes the reaction Arsenic Trioxide] which results in increased expression of CD14 mRNA; Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]; SB 203580 inhibits the reaction [Gefitinib promotes the reaction [Arsenic Trioxide results in increased expression of CD14 protein]] | PMID:20226526 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |